BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Diabetes. Aug 15, 2026; 17(8): 121505
Published online Aug 15, 2026. doi: 10.4239/wjd.121505
Figure 5
Figure 5 Decision curve analysis - clinical utility of the nomogram. Decision curve analysis shows the nomogram (blue) provides substantial net benefit compared to uniform strategies (treat all/none) across 10%-80% threshold probabilities, with peak benefit at 30%-40% (light-blue shaded), supporting risk-stratified clinical implementation.


Write to the Help Desk